📋 Table of Contents
- 1. Introduction
- 2. What is Lenabuzz 10mg Capsule?
- 3. Uses of Lenabuzz 10mg Capsule
- 4. How Lenabuzz 10mg Capsule Works (Mechanism of Action)
- 5. Dosage & Administration
- 6. Side Effects of Lenabuzz 10mg Capsule
- 7. Warnings & Precautions
- 8. Drug Interactions
- 9. Contraindications
- 10. Storage Instructions
- 11. Lenabuzz vs Revlimid: Generic vs Branded
- 12. Frequently Asked Questions (FAQs)
- 13. Conclusion
1. Introduction
Lenabuzz 10mg Capsule is a prescription-based anti-cancer medication manufactured by Jasgur Life Sciences LLP, a renowned pharmaceutical company based in India. This medicine contains Lenalidomide as its active pharmaceutical ingredient, which belongs to a class of drugs known as immunomodulatory agents or IMiDs (Immunomodulatory Imide Drugs).
Lenabuzz is primarily used in the treatment of various hematological (blood-related) cancers, including Multiple Myeloma, Myelodysplastic Syndromes (MDS), Mantle Cell Lymphoma, and Follicular Lymphoma. It represents a cost-effective generic alternative to the patented brand Revlimid® (Bristol-Myers Squibb).
1.1 Why Lenabuzz 10mg is Gaining Popularity
The global oncology market has witnessed a significant shift toward generic medications following the expiration of patents for several blockbuster drugs. Lenalidomide, the active ingredient in Lenabuzz, was originally protected under patent by Bristol-Myers Squibb under the brand name Revlimid®. With the expiration of these patents, multiple pharmaceutical companies, including Jasgur Life Sciences, have launched generic versions like Lenabuzz, making this life-saving medication more accessible and affordable for patients worldwide.
NHS Wales document confirms: “Lenalidomide is now available from other manufacturers because it is no longer protected by a patent. The versions of lenalidomide from other manufacturers are known as generic equivalents. Using generic equivalents can be more cost-effective for the NHS.”
1.2 Understanding the Generic Revolution: Lenabuzz vs. Revlimid
| Aspect | Revlimid® (Branded) | Lenabuzz (Generic) |
|---|---|---|
| Manufacturer | Bristol-Myers Squibb | Jasgur Life Sciences LLP |
| Active Ingredient | Lenalidomide 10mg | Lenalidomide 10mg |
| Bioequivalence | Reference standard | Equivalent to branded |
| Cost | High (Patent protected) | Significantly lower |
| Availability | Limited by patent | Widely available |
2. What is Lenabuzz 10mg Capsule?
Lenabuzz 10mg Capsule is an oral medication used in cancer therapy. Each capsule contains 10mg of Lenalidomide as the active ingredient.
Key Features:
- Prescription-only medicine
- Oral administration (taken by mouth)
- Requires strict adherence to safety protocols (Pregnancy Prevention Program)
- Available in multiple strengths: 2.5mg, 5mg, 10mg, 15mg, 20mg, 25mg
Manufacturer Information:
– Brand: Lenabuzz
– Manufacturer: Jasgur Life Sciences LLP
– Country of Origin: India
– Availability: Licensed pharmacies with prescription
3. Uses of Lenabuzz 10mg Capsule
Based on official prescribing information from the reference brand Revlimid®, Lenabuzz 10mg Capsule is indicated for:
3.1 Multiple Myeloma (MM)
Multiple myeloma is a cancer of plasma cells—a type of white blood cell found in the bone marrow. These cancerous cells accumulate and divide rapidly, leading to bone damage, anemia, kidney problems, and increased infection risk.
Lenabuzz 10mg Capsule is indicated for:
- Newly Diagnosed Multiple Myeloma (Transplant Eligible): As maintenance therapy following autologous stem cell transplantation
- Newly Diagnosed Multiple Myeloma (Transplant Ineligible): In combination with dexamethasone
- Relapsed/Refractory Multiple Myeloma: In combination with dexamethasone for patients who have received at least one prior therapy
3.2 Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes are a group of disorders characterized by abnormal development of blood cells in the bone marrow. Lenabuzz is indicated for the treatment of transfusion-dependent anemia due to low or intermediate-1 risk MDS associated with a deletion 5q cytogenetic abnormality.
Key benefits for MDS patients:
- Reduces the need for frequent blood transfusions
- Improves red blood cell production
- Enhances overall quality of life
- Helps the immune system produce more healthy blood cells in the bone marrow
3.3 Mantle Cell Lymphoma (MCL)
Mantle Cell Lymphoma is a rare and aggressive form of non-Hodgkin lymphoma that affects B-cells. Lenalidomide is indicated for patients with MCL whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.
3.4 Follicular Lymphoma (FL)
Follicular lymphoma is a slow-growing type of non-Hodgkin lymphoma. Lenalidomide in combination with rituximab (an anti-CD20 antibody) is indicated for the treatment of patients with previously treated follicular lymphoma or marginal zone lymphoma.
3.5 Summary Table of Indications
| Condition | Stage/Type | Combination |
|---|---|---|
| Multiple Myeloma | Newly diagnosed (transplant eligible) | Maintenance monotherapy |
| Multiple Myeloma | Newly diagnosed (transplant ineligible) | + Dexamethasone |
| Multiple Myeloma | Relapsed/Refractory | + Dexamethasone |
| Myelodysplastic Syndromes | Low/intermediate risk with del 5q | Monotherapy |
4. How Lenabuzz 10mg Capsule Works (Mechanism of Action)
4.1 Three Primary Mechanisms
1. Direct Anti-cancer Activity:
- Induces cell cycle arrest (stops cancer cells from dividing)
- Promotes apoptosis (programmed cell death) of malignant cells
- Downregulates key transcription factors like IRF4 and MYC
2. Immunomodulatory Effects (Enhancing Immune System):
- Enhances T-cell and NK-cell (Natural Killer cell) activation
- Increases IL-2 and IFN-γ production
- Stimulates the body’s own immune system to recognize and attack cancer cells
3. Anti-angiogenic Effects (Starving the Tumor):
- Inhibits the growth of new blood vessels (angiogenesis)
- Tumors need new blood vessels to grow and spread
- By blocking this process, Lenabuzz effectively “starves” the cancer
5. Dosage & Administration
5.1 Recommended Dosage by Indication
Multiple Myeloma (Newly Diagnosed, Transplant Eligible) — Maintenance:
– Dose: 10mg once daily continuously
– Duration: Until disease progression or unacceptable toxicity
Multiple Myeloma (Newly Diagnosed, Transplant Ineligible):
– Dose: 25mg once daily on days 1-21 of each 28-day cycle
– In combination with: Dexamethasone 40mg once daily on days 1, 8, 15, 22
– Duration: Until disease progression or unacceptable toxicity
Myelodysplastic Syndromes (MDS with del 5q):
– Dose: 10mg once daily for 21 days of each 28-day cycle
– Duration: Until disease progression or unacceptable toxicity
5.2 How to Take Lenabuzz 10mg Capsule
- Swallow whole: Do not break, chew, or open the capsule
- With or without food: Can be taken with or without food
- Same time daily: Take at approximately the same time each day
- Missed dose: If less than 12 hours missed, take immediately. If more than 12 hours missed, skip and take next dose at regular time. Do not double dose.
- Hydration: Maintain adequate hydration during treatment
Important Warning: The medicine should not be opened or crushed. If powder from a broken capsule contacts the skin, wash immediately and thoroughly with soap and water.
5.3 Dose Adjustments for Renal Impairment
| Renal Function (CrCl) | Recommended Dose |
|---|---|
| Normal (≥60 mL/min) | Standard dose (10mg or 25mg as indicated) |
| Moderate (30-59 mL/min) | 10mg once daily |
| Severe (15-29 mL/min) | 5mg once daily (or 10mg every other day) |
| End-stage renal disease (ESRD) on dialysis | 5mg once daily (administer after dialysis) |
6. Side Effects of Lenabuzz 10mg Capsule
6.1 Very Common Side Effects (Affecting >10% of patients)
| Side Effect | Incidence | Management |
|---|---|---|
| Fatigue/Weakness | 60-70% | Rest, nutrition, adjust daily activities |
| Neutropenia (low white blood cells) | 50-60% | Regular blood monitoring, growth factors if needed |
| Thrombocytopenia (low platelets) | 40-50% | Bleeding precautions, platelet transfusions if needed |
| Anemia (low red blood cells) | 30-40% | Blood transfusions, erythropoiesis-stimulating agents |
| Diarrhea | 30-40% | Anti-diarrheal medications, hydration |
| Constipation | 30-40% | Stool softeners, laxatives, increased fluid intake |
| Nausea | 20-30% | Anti-emetics (ondansetron, metoclopramide) |
| Rash | 15-25% | Topical steroids, oral antihistamines |
6.2 Serious Side Effects (Require Immediate Medical Attention)
- Deep Vein Thrombosis (DVT): Leg swelling, pain, warmth
- Pulmonary Embolism (PE): Sudden shortness of breath, chest pain
- Severe neutropenia with fever: Fever, chills, signs of infection
- Severe thrombocytopenia: Unusual bleeding, bruising, petechiae
- Tumor Lysis Syndrome: Nausea, vomiting, muscle cramps, irregular heartbeat
- Stevens-Johnson Syndrome: Widespread rash, blisters, mouth ulcers
- Hepatotoxicity: Jaundice, dark urine, abdominal pain
7. Warnings & Precautions
7.1 Embryo-Fetal Toxicity (Pregnancy Prevention Program)
ABSOLUTELY CRITICAL WARNING: Lenalidomide (Lenabuzz) is STRUCTURALLY RELATED TO THALIDOMIDE, which is known to cause severe, life-threatening birth defects (phocomelia — absence or shortening of limbs, and other deformities) when taken during pregnancy.
For Women of Childbearing Potential (WCBP):
- Must have two negative pregnancy tests before starting treatment (first test: 10-14 days before, second test: within 24 hours of starting)
- Must use two effective forms of contraception simultaneously (including at least one highly effective method like IUD, hormonal implants, or sterilization)
- Contraception must be used for at least 4 weeks before, during, and for 4 weeks after treatment
- Must have pregnancy tests every 4 weeks during treatment
For Men:
- Must use latex condoms during any sexual contact with a woman of childbearing potential
- Do not donate sperm during treatment and for 4 weeks after treatment
Blood Donation Restriction: Patients taking Lenabuzz must NOT donate blood during treatment and for 4 weeks after stopping treatment.
7.2 Hematological Toxicity (Blood Cell Reductions)
Monitoring Requirements:
- Complete blood count (CBC) weekly for the first 8 weeks of treatment
- Then every 2 weeks for the next 4 weeks
- Then monthly thereafter
7.3 Venous and Arterial Thromboembolism (Blood Clots)
Lenalidomide significantly increases the risk of both venous (DVT, PE) and arterial (MI, stroke) blood clots, especially when combined with dexamethasone or other chemotherapeutic agents.
Prevention and Management: Prophylactic anticoagulation (blood thinners) is recommended for patients with multiple risk factors.
8. Drug Interactions
| Drug | Interaction | Recommendation |
|---|---|---|
| Digoxin | Increased digoxin levels (14%) | Monitor digoxin levels periodically |
| Warfarin / Oral Anticoagulants | Increased bleeding risk due to thrombocytopenia | Monitor INR frequently; adjust dose as needed |
| Statins (simvastatin, atorvastatin) | Increased risk of hepatotoxicity and rhabdomyolysis | Monitor liver function and CK levels |
| Dexamethasone | Increased risk of hyperglycemia, hyperlipidemia, fluid retention | Monitor blood sugar, lipid profile, weight |
| Hormonal Contraceptives | Reduced efficacy | Use two effective methods of contraception |
9. Contraindications (When to Avoid)
Absolute Contraindications:
- Pregnancy — Severe, life-threatening birth defects
- Women of childbearing potential not using two effective forms of contraception
- Hypersensitivity (allergy) to lenalidomide or any component
- Concurrent use with other drugs that cause birth defects (e.g., thalidomide)
- Breastfeeding
10. Storage Instructions
| Parameter | Recommendation |
|---|---|
| Temperature | Store at controlled room temperature, 20°C to 25°C (68°F to 77°F) |
| Container | Keep in the original container to protect from moisture and light |
| Keep out of reach of children | Absolutely essential due to severe teratogenic potential |
11. Lenabuzz vs Revlimid: Generic vs Branded Comparison
What is Revlimid?
Revlimid® is the original branded version of lenalidomide, manufactured by Bristol-Myers Squibb. It was first approved by the US FDA in 2005.
11.1 Comparison Table: Lenabuzz vs Revlimid
| Aspect | Revlimid® (Branded) | Lenabuzz (Generic) |
|---|---|---|
| Manufacturer | Bristol-Myers Squibb | Jasgur Life Sciences LLP |
| Active Ingredient | Lenalidomide 10mg | Lenalidomide 10mg |
| Bioequivalence | Reference standard | Bioequivalent |
| Price (US market, 2026) | Approximately $11,000 – $12,000 per month | Approximately $900 – $1,500 per month |
| Price (India) | Not commonly available | Significantly lower |
12. Frequently Asked Questions (FAQs)
Q1: What is Lenabuzz 10mg Capsule used for?
A: Lenabuzz 10mg Capsule is used to treat multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, mantle cell lymphoma, and follicular lymphoma. It works by enhancing the immune system to fight cancer cells and inhibiting the growth of new blood vessels that tumors need to thrive.
Q2: Is Lenabuzz the same as Revlimid?
A: Yes, Lenabuzz contains the same active ingredient (lenalidomide 10mg) as Revlimid and is bioequivalent. It is a generic version of Revlimid, offering the same therapeutic effect at a lower cost.
Q3: Is Lenabuzz 10mg Capsule safe during pregnancy?
A: ABSOLUTELY NOT. Lenabuzz is structurally related to thalidomide, which causes severe, life-threatening birth defects. It is contraindicated during pregnancy. Women of childbearing potential must use two effective forms of contraception for at least 4 weeks before, during, and for 4 weeks after treatment.
Q4: How long does it take for Lenabuzz to work?
A: Response times vary depending on the indication and individual patient. Some patients may show improvement in blood counts or cancer markers within a few weeks, while others may require several months of treatment. Your doctor will monitor your response through regular blood tests and imaging studies.
Q5: What are the most common side effects of Lenabuzz?
A: The most common side effects (affecting >10% of patients) include fatigue, neutropenia (low white blood cells), thrombocytopenia (low platelets), anemia, diarrhea, constipation, nausea, rash, muscle cramps, and swelling (edema).
Q6: Can I stop Lenabuzz if I feel better?
A: No. Do not stop taking Lenabuzz without consulting your doctor, even if you feel better. Stopping treatment could allow the cancer to grow or relapse. Your doctor will determine the appropriate duration of treatment based on your specific condition and response.
Q7: What should I do if I miss a dose?
A: If less than 12 hours have passed since your scheduled dose, take the missed dose immediately. If more than 12 hours have passed, skip the missed dose and take your next dose at the regular time. Do not double the dose to make up for a missed one.
Q8: Can I drink alcohol while taking Lenabuzz?
A: Alcohol does not directly interact with lenalidomide. However, alcohol can worsen certain side effects such as nausea, dizziness, and dehydration. It is best to limit or avoid alcohol consumption during treatment. Discuss this with your doctor.
Q9: Can I get vaccinated while taking Lenabuzz?
A: Avoid live vaccines (MMR, varicella, zoster, nasal flu vaccine) during treatment, as lenalidomide suppresses the immune system and may increase the risk of vaccine-related infection. Inactivated vaccines (e.g., flu shot, pneumonia vaccine, COVID-19 vaccine) are generally safe but may be less effective. Discuss vaccination with your doctor before receiving any vaccine.
Q10: Can I donate blood while taking Lenabuzz?
A: No. Patients taking Lenabuzz must NOT donate blood during treatment and for 4 weeks after stopping treatment.
Q11: How should I store Lenabuzz 10mg Capsule?
A: Store at room temperature (20°C to 25°C / 68°F to 77°F) in the original container, away from moisture and light. Keep out of reach of children. Do not use after the expiration date.
Q12: Can men take Lenabuzz if their partner is pregnant?
A: Men should use condoms during any sexual contact with a pregnant partner, as lenalidomide may be present in semen. Men should also not donate sperm during treatment and for 4 weeks after stopping treatment.
Q13: What blood tests will I need while taking Lenabuzz?
A: You will need: Complete blood count (CBC) weekly for first 8 weeks, then every 2 weeks, then monthly; Liver function tests (LFTs) before treatment, then every 2-4 weeks; Pregnancy tests (for women) before treatment and every 4 weeks; Renal function tests periodically.
Q14: Can I take other medications while on Lenabuzz?
A: Always inform your doctor about all medications you are taking. Lenabuzz interacts with digoxin, warfarin, statins, and hormonal contraceptives. Your doctor may need to adjust doses or monitor you more closely.
Q15: Is Lenabuzz available as a 25mg strength?
A: Yes, Lenabuzz is available in multiple strengths including 2.5mg, 5mg, 10mg, 15mg, 20mg, and 25mg. The 25mg strength is commonly used for multiple myeloma treatment protocols.
13. Conclusion
Lenabuzz 10mg Capsule is a highly effective, generic alternative to branded Revlimid for the treatment of several serious hematologic malignancies, including multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, mantle cell lymphoma, and follicular lymphoma. By containing the same active ingredient (lenalidomide) and being bioequivalent to the reference product, Lenabuzz offers the same therapeutic benefits at a significantly lower cost.
Key Takeaways:
- Efficacy: Lenabuzz 10mg works through multiple mechanisms (direct anti-cancer activity, immunomodulation, anti-angiogenesis) to fight cancer cells and improve patient outcomes.
- Safety: While generally well-tolerated, Lenabuzz has significant risks, including severe birth defects (requiring a strict Pregnancy Prevention Program), blood clots, low blood counts, and liver damage. Regular monitoring is essential.
- Dosing: The 10mg strength is commonly used for MDS and maintenance therapy for multiple myeloma. Dosing varies based on indication, renal function, and individual tolerance.
- Cost-effectiveness: As a generic medication, Lenabuzz is significantly more affordable than branded Revlimid, improving access to this life-saving treatment for patients worldwide.
Important Note: This information is for educational purposes only and does not constitute medical advice. Lenabuzz 10mg Capsule should only be used under the supervision of a qualified healthcare professional experienced in the management of hematological malignancies. Always consult your doctor before starting, stopping, or changing any medication.
14. References & Sources
- Bristol-Myers Squibb — Official Revlimid® (lenalidomide) Prescribing Information
- U.S. Food and Drug Administration (FDA) — FDA Lenalidomide (Revlimid) Information
- European Medicines Agency (EMA) — Revlimid (lenalidomide) Assessment Report
- NHS Wales (UK National Health Service) — What is Lenalidomide? Patient Information Leaflet
- National Comprehensive Cancer Network (NCCN) — Multiple Myeloma Guidelines
- Drugs.com — Lenalidomide: Mechanism of Action, Side Effects, Dosage
- PubMed Central (PMC) — Lenalidomide: A Review of Its Use in Hematologic Malignancies
- MedlinePlus (U.S. National Library of Medicine) — Lenalidomide: Patient Information
- WebMD — Lenalidomide Oral: Uses, Side Effects, Interactions
- Mayo Clinic — Lenalidomide (Oral Route) – Description & Brand Names
- Cancer Research UK — Lenalidomide (Revlimid) – Patient Information
- Jasgur Life Sciences LLP — Lenabuzz (Lenalidomide) Product Monograph
- Central Drugs Standard Control Organization (CDSCO), India — Generic Lenalidomide Approval List
Medical Disclaimer: The information provided on this page is for educational and informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting, stopping, or changing any medication. Lenabuzz 10mg Capsule is a prescription-only medication and should only be used under the supervision of a licensed physician. The manufacturer, Jasgur Life Sciences LLP, does not endorse or assume responsibility for the information presented here. Readers are encouraged to verify all information with their healthcare provider and official prescribing information.
Last Updated: June 2026
There are no reviews yet.